Ingevity Rises More Than 18% in 3 Months: What's Driving the Stock?

Core Insights - Ingevity Corporation's shares have increased by 18.7% over the past three months, outperforming the Zacks Chemical - Specialty industry's growth of 4.8% and the S&P 500's increase of 6.3% during the same period [1][7] Group 1: Strategic Actions - The company optimized its portfolio by selling its North Charleston crude tall oil (CTO) refinery assets and the majority of the Performance Chemicals Industrial Specialties product line to Mainstream Pine Products for $110 million in cash, with potential contingent consideration of up to $19 million based on future performance milestones, contributing to the rise in share price [3][4][7] - By divesting CTO-based product lines while retaining the Pavement Technologies business and other lignin-based dispersant products, Ingevity is focusing on higher-margin specialty applications and enhancing capital efficiency [4] Group 2: Acquisitions and Growth - Ingevity's disciplined acquisition strategy has significantly strengthened its portfolio and earnings quality, with the acquisition of Georgia-Pacific's pine chemicals leading to improved production efficiency, reduced sourcing and logistics costs, and enhanced margins [5] - The acquisition of Capa caprolactone introduced a differentiated technology platform applicable across coatings, adhesives, and specialty polymers, creating a sustainable and higher-quality revenue stream [5] - The Ozark Materials acquisition expanded Ingevity's presence in the construction and infrastructure markets, positioning the company to benefit from long-term infrastructure demand [6]